Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Lichen Planus Following Hepatitis B Vaccination

Lichen Planus Following Hepatitis B Vaccination Abstract The association of lichen planus (LP) with liver diseases, first described in 1978 by Rebora et al,1 has successively been confirmed by numerous observations.2 However, the role played by hepatitis B virus (HBV) infection remains to be explained. We describe a man in whom LP developed after an HBV vaccination. Two analogous cases have been observed previously,3,4 and our observation suggests that the vaccine could be involved in the pathogeny. Report of a Case. A 50-year-old man who was at risk forHBV infection received HBV vaccine (Gen Hevac B, Pasteur Institute, Paris, France). This is a noninfectant recombinant vaccine produced in mammalian cells, which contains the S and pre-S2 antigens involving the products of the S and pre-S2 regions of HBV DNA. The first dose of vaccine (0.5 mL) was given to our patient in June 1992 and the second (0.5 mL) 1 month later. In August, References 1. Rebora A, Patri PL, Rampini E, Crovato F, Ciravegna G. Erosive lichen pla- nus and cirrhotic hepatitis . It Gen Rev Dermatol. 1978;18:123-127. 2. Cascinelli T. Lichen planus and liver diseases: a multicenter case control study . BMJ. 1990;300:227-230.Crossref 3. Ciaccio M, Rebora A. Lichen planus following HBV vaccination: a coincidence? Br J Dermatol. 1990;122:424.Crossref 4. Trevisan G, Stinco G. Lichen ruber planus following HBV vaccination . Acta Derm Venereol (Stockh) . 1993;73:73. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Dermatology American Medical Association

Lichen Planus Following Hepatitis B Vaccination

Loading next page...
 
/lp/american-medical-association/lichen-planus-following-hepatitis-b-vaccination-mGteOeQjZw
Publisher
American Medical Association
Copyright
Copyright © 1994 American Medical Association. All Rights Reserved.
ISSN
0003-987X
eISSN
1538-3652
DOI
10.1001/archderm.1994.01690100119025
Publisher site
See Article on Publisher Site

Abstract

Abstract The association of lichen planus (LP) with liver diseases, first described in 1978 by Rebora et al,1 has successively been confirmed by numerous observations.2 However, the role played by hepatitis B virus (HBV) infection remains to be explained. We describe a man in whom LP developed after an HBV vaccination. Two analogous cases have been observed previously,3,4 and our observation suggests that the vaccine could be involved in the pathogeny. Report of a Case. A 50-year-old man who was at risk forHBV infection received HBV vaccine (Gen Hevac B, Pasteur Institute, Paris, France). This is a noninfectant recombinant vaccine produced in mammalian cells, which contains the S and pre-S2 antigens involving the products of the S and pre-S2 regions of HBV DNA. The first dose of vaccine (0.5 mL) was given to our patient in June 1992 and the second (0.5 mL) 1 month later. In August, References 1. Rebora A, Patri PL, Rampini E, Crovato F, Ciravegna G. Erosive lichen pla- nus and cirrhotic hepatitis . It Gen Rev Dermatol. 1978;18:123-127. 2. Cascinelli T. Lichen planus and liver diseases: a multicenter case control study . BMJ. 1990;300:227-230.Crossref 3. Ciaccio M, Rebora A. Lichen planus following HBV vaccination: a coincidence? Br J Dermatol. 1990;122:424.Crossref 4. Trevisan G, Stinco G. Lichen ruber planus following HBV vaccination . Acta Derm Venereol (Stockh) . 1993;73:73.

Journal

Archives of DermatologyAmerican Medical Association

Published: Oct 1, 1994

References